Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: Comparison of three homogeneous methods

Clinica Chimica Acta

Volumn 295, Issue 1-2, 2000, Pages 97-106

  Sakaue, Taro ^a   Hirano, Tsutomu ^a   Yoshino, Gen ^b   Sakai, Keiko ^a   Takeuchi, Hiroko ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Direct LDL cholesterol assay; Homogeneous method; IDL; Type III dysbetalipoproteinemia; VLDL

Indexed keywords

INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; AUTOMATION; CASE REPORT; CONTROLLED STUDY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; HYPERLIPOPROTEINEMIA TYPE 3; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; TECHNIQUE; ULTRACENTRIFUGATION;

CHOLESTEROL; CHOLESTEROL, LDL; HUMANS; LIPOPROTEINS; REAGENT KITS, DIAGNOSTIC; ULTRACENTRIFUGATION;

EID: 0034037330     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00200-X     Document Type: Article

References (10)

1. Tatami R., Mabuchi H., Ueda K., Ueda R., Haba T., Kametani T., Ito S., Koizumi J., Ohta M., Miyamoto S., Nakayama A., Kanaya H., Oiwake H., Genda A., Takeda R. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation. 64:1981;1174-1184.
2. Sutherland W.H., Restieaux N.J., Nye E.R., Williams M.J., de Jong S.A., Robertson M.C., Walker H.L. IDL composition and angiographically determined progression of atherosclerotic lesions during simvastatin therapy. Arterioscler Thromb Vasc Biol. 18:1998;577-583.
3. Hodis H.N., Mack W.J., Dunn M., Liu C., Liu C., Selzer R.H., Krauss R.M. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation. 95:1997;2022-2026.
4. Marley R.W., Rall S.C. Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver C.R., Beaudet A.L., Sly W.S., et al. In the metabolic and molecular basis of inherited disease. 7th ed. 1995;1953-1980 McGraw-Hill, New York.
5. Manual of laboratory operation: Lipid Research Clinics Program. vol. 1, DHEW publication no. (NIH) 75-628. Washington, DC: Department of Health, Education, and Welfare, 1974.
6. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
7. Freidewald W.T., Levy R.I., Fredrikson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
8. Okada M., Mitsui H., Ito Y., Fujiwara A., Inano K. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J Lab Clin Med. 132:1998;195-201.
9. Nakamura M., Taniguchi Y., Yamamoto M., Hino K., Manabe M. Homogenous assay of serum LDL-cholesterol on an automatic analyzer. Clin Chem. 43:1997;S260.
10. Sugiuchi H., Irie T., Uji Y., Ueno T., Chaen T., Uekama K., Okabe H. Homogenous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. Clin Chem. 44:1998;522-531.